Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Short-term Investments (2017 - 2025)

Historic Short-term Investments for Cue Biopharma (CUE) over the last 8 years, with Q3 2025 value amounting to $7.0 million.

  • Cue Biopharma's Short-term Investments changed N/A to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year change of. This contributed to the annual value of $929000.0 for FY2024, which is 22369.34% up from last year.
  • Per Cue Biopharma's latest filing, its Short-term Investments stood at $7.0 million for Q3 2025.
  • Cue Biopharma's 5-year Short-term Investments high stood at $29.5 million for Q3 2022, and its period low was $287000.0 during Q4 2023.
  • In the last 4 years, Cue Biopharma's Short-term Investments had a median value of $5.0 million in 2023 and averaged $8.7 million.
  • As far as peak fluctuations go, Cue Biopharma's Short-term Investments tumbled by 9883.69% in 2023, and later soared by 22369.34% in 2024.
  • Quarter analysis of 4 years shows Cue Biopharma's Short-term Investments stood at $24.7 million in 2022, then plummeted by 98.84% to $287000.0 in 2023, then surged by 223.69% to $929000.0 in 2024, then surged by 653.5% to $7.0 million in 2025.
  • Its last three reported values are $7.0 million in Q3 2025, $470000.0 for Q2 2025, and $912000.0 during Q1 2025.